Human CYP2A13 and CYP2F1 Mediate Naphthalene Toxicity in the Lung and Nasal Mucosa of CYP2A13/2F1-Humanized Mice
Open Access
- 23 June 2017
- journal article
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 125 (6) , 067004
Abstract
The potential carcinogenicity of naphthalene (NA), a ubiquitous environmental pollutant, in human respiratory tract is a subject of intense debate. Chief among the uncertainties in risk assessment for NA is whether human lung CYP2A13 and CYP2F1 can mediate NA's respiratory tract toxicity. We aimed to assess the in vivo function of CYP2A13 and CYP2F1 in NA bioactivation and NA-induced respiratory tract toxicity in mouse models. Rates of microsomal NA bioactivation and the effects of an anti-CYP2A antibody were determined for lung and nasal olfactory mucosa (OM) from Cyp2abfgs-null, CYP2A13-humanized, and CYP2A13/2F1-humanized mice. The extent of NA respiratory toxicity was compared among wild-type, Cyp2abfgs-null, and CYP2A13/2F1-humanized mice following inhalation exposure at an occupationally relevant dose (10 ppm for 4 hr). In vitro studies indicated that the NA bioactivation activities in OM and lung of the CYP2A13/2F1-humanized mice were primarily contributed by, respectively, CYP2A13 and CYP2F1. CYP2A13/2F1-humanized mice showed greater sensitivity to NA than Cyp2abfgs-null mice, with greater depletion of nonprotein sulfhydryl and occurrence of cytotoxicity (observable by routine histology) in the OM, at 2 or 20 hr after termination of NA exposure, in humanized mice. Focal, rather than gross, lung toxicity was observed in Cyp2abfgs-null and CYP2A13/2F1-humanized mice; however, the extent of NA-induced lung injury (shown as volume fraction of damaged cells) was significantly greater in the terminal bronchioles of CYP2A13/2F1-humanized mice than in Cyp2abfgs-null mice. CYP2F1 is an active enzyme. Both CYP2A13 and CYP2F1 are active toward NA in the CYP2A13/2F1-humanized mice, where they play significant roles in NA-induced respiratory tract toxicity. https://doi.org/10.1289/EHP844.Keywords
This publication has 45 references indexed in Scilit:
- Generation and Characterization of a CYP2A13/2B6/2F1-Transgenic Mouse ModelDrug Metabolism and Disposition, 2012
- Generation and Characterization of a Cyp2f2-Null Mouse and Studies on the Role of CYP2F2 in Naphthalene-Induced Toxicity in the Lung and Nasal Olfactory MucosaThe Journal of Pharmacology and Experimental Therapeutics, 2011
- 3-Methylindole Metabolites Induce Lung CYP1A1 and CYP2F1 Enzymes by AhR and Non-AhR Mechanisms, RespectivelyChemical Research in Toxicology, 2010
- Multiple-Approaches to the Identification and Quantification of Cytochromes P450 in Human Liver Tissue by Mass SpectrometryJournal of Proteome Research, 2008
- EXPRESSION OF CYTOCHROME P450 AND OTHER BIOTRANSFORMATION GENES IN FETAL AND ADULT HUMAN NASAL MUCOSADrug Metabolism and Disposition, 2005
- Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus MacaqueThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding MotifJournal of Biological Chemistry, 2003
- NAPHTHALENE-INDUCED RESPIRATORY TRACT TOXICITY: METABOLIC MECHANISMS OF TOXICITYDrug Metabolism Reviews, 2002
- TOXICITY AND CARCINOGENICITY STUDY IN F344 RATS FOLLOWING 2 YEARS OF WHOLE-BODY EXPOSURE TO NAPHTHALENE VAPORSInhalation Toxicology, 2001
- Naphthalene: A Respiratory Tract Toxicant and Carcinogen for MiceInhalation Toxicology, 1992